Clinical Oncology Next-Generation Sequencing Market Report Overview
Maximise Market Research has issued papers to help clients understand the landscape of the Clinical Oncology Next-Generation Sequencing Market in which they compete. The research provides market insights to help clients understand future demand for their product and the Clinical Oncology Next-Generation Sequencing’s competitiveness. The Clinical Oncology Next-Generation Sequencing market overview provides detailed information on the market’s size, trade data, key players, and several market metrics such as life cycle, trends, and so on.
Grab your free sample copy of this report now @ https://www.maximizemarketresearch.com/request-sample/100383
Clinical Oncology Next-Generation Sequencing Market Growth:
Clinical Oncology Next-Generation Sequencing Market size was valued at USD 9.49 Billion in 2023 and the total Clinical Oncology Next-Generation Sequencing revenue is expected to grow at a CAGR of 20.7 % from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030.
Clinical Oncology Next-Generation Sequencing Market Report Scope and Research Methodology
The Clinical Oncology Next-Generation Sequencing market report delves into the importance of segments and regional markets, based on factors like market size and growth rate. A comprehensive overview of all segments and regions is outlined within the report. An in-depth analysis of projected statistics, significant developments, and revenue is encompassed in the Clinical Oncology Next-Generation Sequencing market report. It also entails a thorough examination of the key strategies employed by leading market players to enhance business growth on a global scale while maintaining a competitive edge. The research on the Clinical Oncology Next-Generation Sequencing market encompasses an evaluation of production, consumption, revenue, market share, and growth rates across the following regions: North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. The application of SWOT analysis offers insights into the strengths and weaknesses of the Clinical Oncology Next-Generation Sequencing market.
Market Dynamics:
Rising global cancer burden boosts demand for precise genomic analysis, propelling clinical oncology next-generation sequencing market growth.
Continuous improvements in NGS technology are boosting the Clinical Oncology Next-Generation Sequencing Market. For example, Illumina’s NovaSeq platform will revolutionise cancer genome analysis by increasing sequencing speed and accuracy. This innovation propels market expansion by allowing for speedy and cost-effective genomic profiling in oncology research and clinical applications. The rising worldwide cancer burden, particularly in emerging countries, increases the need for accurate genomic analysis afforded by NGS. Thermo Fisher’s Oncomine tests, which provide full molecular profile, address this requirement by facilitating targeted therapy selection and monitoring, hence accelerating market expansion amid escalating cancer incidence estimates.
Clinical Oncology Next-Generation Sequencing Market Regional Insights:
The report is segmented into several key countries, with market size, growth rate, import and export of EV Connectors market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa.
Clinical Oncology Next-Generation Sequencing Market Segmentation:
by Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others
by Workflow
Pre-Sequencing
Sequencing
Data Analysis
by Application
Screening
Diagnostics
by End-User
Hospitals
Clinics
Based on technology, Whole Genome Sequencing dominated the Clinical Oncology Next-Generation Sequencing Market in 2023. It provides a comprehensive view of an individual’s entire genome, allowing for the identification of novel mutations and complex structural variations, but its adoption is hampered by high costs and extensive data analysis. Whole Exome Sequencing (WES) focuses on sequencing the genome’s protein-coding regions, providing a balance of cost-effectiveness and extensive genomic coverage, making it ideal for finding cancer-related coding mutations. Targeted Sequencing, on the other hand, selectively reads specific regions of interest, resulting in excellent sensitivity and cost efficiency, especially when discovering known cancer-associated mutations. Other developing technologies, like as RNA sequencing or single-cell sequencing, provide additional insights into tumour biology and heterogeneity.
Curious about the content? Explore a sample copy of this report
Clinical Oncology Next-Generation Sequencing Market Key Players:
Major Contributors in the Clinical Oncology Next-Generation Sequencing Industry in North America:
1. Illumina, Inc.., San Diego, California, USA
2. Thermo Fisher Scientific, Inc., Waltham, Massachusetts, USA
3. Guardant Health, Inc., Redwood City, California, USA
4. PPacific Bioscience of California, Inc., Menlo Park, California, USA
5. Agilent Technologies, Inc., Santa Clara, California, USA
Leading players in the Europe Clinical Oncology Next-Generation Sequencing Market:
1. Qiagen N.V., Venlo, Netherlands
2. Roche Holdings AG (including Foundation Medicine), Basel, Switzerland
3. Oxford Nanopore Technologies Ltd., Oxford, United Kingdom
4. Genewiz Germany GmbH, Leipzig, Germany
5. Sophia Genetics SA, Saint-Sulpice, Switzerland
Key players driving the Asia-Pacific Clinical Oncology Next-Generation Sequencing Market:
1. Novogene Corporation, Beijing, China
2. BGI Group, Shenzhen, China
3. Takara Bio Inc., Kusatsu, Japan
4. MedGenome Labs Pvt. Ltd., Bengaluru, India
Table of Content: Clinical Oncology Next-Generation Sequencing Market
Part 01: Executive Summary
Part 02: Scope of the Clinical Oncology Next-Generation Sequencing Market Report
Part 03: Clinical Oncology Next-Generation Sequencing Market Landscape
Part 04: Clinical Oncology Next-Generation Sequencing Market Sizing
Part 05: Clinical Oncology Next-Generation Sequencing Market Segmentation by Type
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Key questions answered in the Clinical Oncology Next-Generation Sequencing Market are:
- What are the Clinical Oncology Next-Generation Sequencing Market segments?
- Which Clinical Oncology Next-Generation Sequencing market segment is expected to grow rapidly during the forecast period?
- What is the expected CAGR of the Clinical Oncology Next-Generation Sequencing market during the forecast period?
- Who are the top players in the Clinical Oncology Next-Generation Sequencing industry?
- Which region is expected to grow at a high CAGR during the forecast period?
- Which region held the largest Clinical Oncology Next-Generation Sequencing market share in 2024?
Explore additional details by clicking the link provided@ https://www.maximizemarketresearch.com/request-sample/100383
Key Offerings:
- Market Overview
- Market Share
- Market Size
- Forecast by Revenue | 2024−2030
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
- Market Segmentation – A detailed analysis by segments, sub-segments and region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
More Related Reports:
Energy Efficient Lighting Market https://www.maximizemarketresearch.com/market-report/global-energy-efficient-lighting-market/33568/
Global Tortilla Market https://www.maximizemarketresearch.com/market-report/tortilla-market/127189/
